About Us

Content

Opti-K® treatments have been given to over 200 patients at the Vision Rejuvenation® Center in Nassau, Bahamas to correct hyperopia (farsightedness) and to improve near vision as part of an ongoing Nassau Clinical Study with follow-up that extends to two years after Opti-K® treatment. Outcomes of the Nassau Clinical Study have been presented at international ophthalmology conferences and manuscripts are in preparation for submission to peer-reviewed journals for publication. Abstracts summarizing the Nassau Clinical Study are available on the Download More Information page of this website.

In the United States, Opti-K® is only available for investigational use to treat patients enrolled in the U.S. Clinical Trial.